1489 related articles for article (PubMed ID: 18640474)
1. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
2. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED.
Schreck DM; Babin S
Am J Emerg Med; 2005 Nov; 23(7):842-7. PubMed ID: 16291438
[TBL] [Abstract][Full Text] [Related]
3. Comparison of racemic albuterol and levalbuterol for treatment of acute asthma.
Carl JC; Myers TR; Kirchner HL; Kercsmar CM
J Pediatr; 2003 Dec; 143(6):731-6. PubMed ID: 14657817
[TBL] [Abstract][Full Text] [Related]
4. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma.
Brunetti L; Poiani G; Dhanaliwala F; Poppiti K; Kang H; Suh DC
Am J Health Syst Pharm; 2015 Jun; 72(12):1026-35. PubMed ID: 26025994
[TBL] [Abstract][Full Text] [Related]
6. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
7. Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma.
Truitt T; Witko J; Halpern M
Chest; 2003 Jan; 123(1):128-35. PubMed ID: 12527613
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
Berger WE; Milgrom H; Skoner DP; Tripp K; Parsey MV; Baumgartner RA;
Curr Med Res Opin; 2006 Jun; 22(6):1217-26. PubMed ID: 16846555
[TBL] [Abstract][Full Text] [Related]
9. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
Dalonzo GE
J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.
Hamilos DL; D'Urzo A; Levy RJ; Marcus M; Tripp K; Parsey M; Baumgartner RA; McVicar WK
Ann Allergy Asthma Immunol; 2007 Dec; 99(6):540-8. PubMed ID: 18219836
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma.
Qureshi F; Zaritsky A; Welch C; Meadows T; Burke BL
Ann Emerg Med; 2005 Jul; 46(1):29-36. PubMed ID: 15988423
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
13. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
[TBL] [Abstract][Full Text] [Related]
14. Racemic epinephrine compared to salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial [ISRCTN46561076].
Langley JM; Smith MB; LeBlanc JC; Joudrey H; Ojah CR; Pianosi P
BMC Pediatr; 2005 May; 5(1):7. PubMed ID: 15876347
[TBL] [Abstract][Full Text] [Related]
15. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
16. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
Schermer TR; Albers JM; Verblackt HW; Costongs RJ; Westers P
Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
Raissy HH; Harkins M; Esparham A; Kelly HW
Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[TBL] [Abstract][Full Text] [Related]
19. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs.
Drescher GS; Carnathan BJ; Imus S; Colice GL
Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma.
Skoner DP; Greos LS; Kim KT; Roach JM; Parsey M; Baumgartner RA
Pediatr Pulmonol; 2005 Dec; 40(6):477-86. PubMed ID: 16193496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
